128 related articles for article (PubMed ID: 36639280)
21. Identifying optimal surgical approach among T1N2-3M0 non-small cell lung cancer patients: a population-based analysis.
Ge T; Hu SQ; Ning J; Zhou YF; Bian DL; Teng MX; Chen LS; Yang J
Transl Lung Cancer Res; 2024 Apr; 13(4):901-929. PubMed ID: 38736488
[TBL] [Abstract][Full Text] [Related]
22. Association between number of dissected lymph nodes and survival in stage IA non-small cell lung cancer: a propensity score matching analysis.
Wu LL; Lai JJ; Liu X; Huang YY; Lin P; Long H; Zhang LJ; Ma GW
World J Surg Oncol; 2020 Dec; 18(1):322. PubMed ID: 33287841
[TBL] [Abstract][Full Text] [Related]
23. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
Moon MH; Moon YK; Moon SW
Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
[TBL] [Abstract][Full Text] [Related]
24. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
[TBL] [Abstract][Full Text] [Related]
25. Choice of surgical procedure - lobectomy, segmentectomy, or wedge resection - for patients with stage T1-2N0M0 small cell lung cancer: A population-based study.
Liu Y; Shan L; Shen J; Liu L; Wang J; He J; He Q; Jiang L; Guo M; Chen X; Zeng H; Xia X; Peng G; Liang W; He J
Thorac Cancer; 2019 Apr; 10(4):593-600. PubMed ID: 30854808
[TBL] [Abstract][Full Text] [Related]
26. Meta-analysis of lobectomy, segmentectomy, and wedge resection for stage I non-small cell lung cancer.
Zhang Y; Sun Y; Wang R; Ye T; Zhang Y; Chen H
J Surg Oncol; 2015 Mar; 111(3):334-40. PubMed ID: 25322915
[TBL] [Abstract][Full Text] [Related]
27. Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
Yendamuri S; Dhillon SS; Groman A; Dy G; Dexter E; Picone A; Nwogu C; Demmy T; Hennon M
J Thorac Cardiovasc Surg; 2018 Jul; 156(1):394-402. PubMed ID: 29709364
[TBL] [Abstract][Full Text] [Related]
28. Lobectomy Versus Sublobectomy in Stage IIIA/N2 Non-Small Cell Lung Cancer: A Population-Based Study.
Wang S; Zhang Z; Gu Y; Lv X; Shi X; Liu M
Front Oncol; 2021; 11():726811. PubMed ID: 34956862
[TBL] [Abstract][Full Text] [Related]
29. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
[TBL] [Abstract][Full Text] [Related]
30. The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer.
Stiles BM; Kamel MK; Nasar A; Harrison S; Nguyen AB; Lee P; Port JL; Altorki NK
Eur J Cardiothorac Surg; 2017 Mar; 51(3):511-517. PubMed ID: 28007869
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcomes of stage I NSCLC (≤3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis.
Qu X; Wang K; Zhang T; Shen H; Dong W; Liu Q; Du J
J Thorac Dis; 2017 Nov; 9(11):4561-4573. PubMed ID: 29268526
[TBL] [Abstract][Full Text] [Related]
32. Long-term survival analysis of sublobar resection versus lobectomy for older patients with early-stage pulmonary carcinoid tumour: a database-based propensity score-matched study.
Yang H; Xiao X; Mei T; Zhou P
Aging Clin Exp Res; 2022 Aug; 34(8):1925-1934. PubMed ID: 35347580
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Significance of Lymph Node Count Removed at Sublobar Resection in Pathologic Stage IA Non-Small-cell Lung Cancer: A Population-Based Analysis.
He Z; Li Z; Xu S; Wu W; Zhu Q; Wang J; Wen W; Chen L
Clin Lung Cancer; 2021 Jul; 22(4):e563-e573. PubMed ID: 33214078
[TBL] [Abstract][Full Text] [Related]
34. Survival after wedge resection versus lobectomy for stage IA second primary NSCLC with previous lung cancer-directed surgery.
Song C; Lu Z; Li D; Pan S; Li N; Geng Q
Front Oncol; 2022; 12():890033. PubMed ID: 36033457
[TBL] [Abstract][Full Text] [Related]
35. Surgical resection versus radiotherapy for clinical stage IA lung cancer ≤1 cm in size: A population-based study.
Huang W; Deng HY; Wu XN; Xu K; Li P; Lin MY; Yuan C; Zhou Q
Asian J Surg; 2023 Jan; 46(1):385-393. PubMed ID: 35525696
[TBL] [Abstract][Full Text] [Related]
36. Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303.
Mimae T; Saji H; Nakamura H; Okumura N; Tsuchida M; Sonobe M; Miyazaki T; Aokage K; Nakao M; Haruki T; Okada M; Suzuki K; Chida M
Ann Surg Oncol; 2021 Nov; 28(12):7219-7227. PubMed ID: 33900499
[TBL] [Abstract][Full Text] [Related]
37. Sublobar resection versus lobectomy for patients with stage T1-2N0M0 pulmonary typical carcinoid tumours: a population-based propensity score matching analysis.
Yang H; Mei T
Interact Cardiovasc Thorac Surg; 2022 Aug; 35(3):. PubMed ID: 35512177
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant treatment can improve prognosis in patients with non-small cell lung cancer ≤3 cm after sublobectomy: a propensity score analysis.
Ma H; Cheng J; Yu Y; Liu B; Qin J; Xing W; Luo S
J Thorac Dis; 2021 Jan; 13(1):312-321. PubMed ID: 33569211
[TBL] [Abstract][Full Text] [Related]
39. Surgery for advanced-stage non-small cell lung cancer: lobectomy or sub-lobar resection?
Hao Z; Liang H; Zhang Y; Wei W; Lan Y; Qiu S; Lin G; Wang R; Liu Y; Chen Y; Huang J; Wang W; Cui F; Goto T; Jeong JY; Veronesi G; Lopez-Pastorini A; Igai H; Liang W; He J; Liu J
Transl Lung Cancer Res; 2021 Mar; 10(3):1408-1423. PubMed ID: 33889519
[TBL] [Abstract][Full Text] [Related]
40. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data.
Kates M; Swanson S; Wisnivesky JP
Chest; 2011 Mar; 139(3):491-496. PubMed ID: 20576736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
